Pyrazole scaffold: a remarkable tool in the development of anticancer agents

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Pharmacology

Background:

• Pyrazole derivatives exhibit broad-spectrum pharmacological activities.
• Structural modifications of pyrazoles are explored for enhanced biological potential.
• Cancer remains a significant global health challenge requiring novel therapeutic strategies.

Purpose of the Study:

• To review the application of molecular modeling in designing novel pyrazole analogs for cancer therapy.
• To identify pyrazole analogs targeting key cancer-related receptors.
• To discuss the future perspectives of pyrazoles in cancer research.

Main Methods:

• Literature review focusing on molecular modeling studies of pyrazole derivatives.
• Analysis of pyrazole analogs designed to interact with specific cancer targets.
• Identification of structure-activity relationships through computational approaches.

Main Results:

• Molecular modeling facilitates the rational design of pyrazole-based inhibitors.
• Identified pyrazole analogs target crucial receptors like protein kinase, tyrosine kinase, Aurora-A kinase, TGF-β, CDK, and FGF.
• These targeted receptors are significant in various cancer pathways.

Conclusions:

• Molecular modeling is a powerful tool for developing targeted cancer therapeutics based on pyrazole scaffolds.
• Pyrazole derivatives hold significant promise for future cancer treatment development.
• Further research into pyrazole analogs could lead to effective anti-cancer drugs.